Trials / Unknown
UnknownNCT05493644
A Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 660 (estimated)
- Sponsor
- Shandong University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The patients who accepted the quadruple eradication program of the helicobacter pylori but failed to eradicate helicobacter pylori will be assessed the most suitable re-eradication time of helicobacter pylori.
Detailed description
Helicobacter pylori (HP) infection is a common global infectious disease, which is an important cause of chronic gastritis, peptic ulcer and gastric cancer. At present, due to the non-standard Helicobacter pylori eradication program in clinical work, poor patient compliance and other reasons, the phenomenon of HP eradication treatment failure is more and more common. However, there is still no conclusion on the most appropriate time for remedial treatment inpatients with Hp eradication failure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Remedial treatment within 3 months | Remedial therapy was performed within 3 months |
| OTHER | Remedial treatment within 3 to 6 months | Remedial therapy was performed within 3 to 6 months |
| OTHER | Remedial treatment within 6 to 12 months | Remedial therapy was performed within 6 to 12 months |
| OTHER | Remedial treatment after 12 months | Remedial therapy was performed after 12 months |
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2023-08-31
- Completion
- 2023-12-31
- First posted
- 2022-08-09
- Last updated
- 2022-08-09
Source: ClinicalTrials.gov record NCT05493644. Inclusion in this directory is not an endorsement.